NCT05857137View on ClinicalTrials.gov

Psychosis TMS Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

March 15, 2026

Study Completion Date

June 30, 2026

Conditions
Psychosis
Interventions
DEVICE

Active TMS

Continuous theta burst stimulation (cTBS) will be administered over the left inferior parietal lobule for approximately 3 minutes at 120% of the resting motor threshold.

DEVICE

Placebo TMS

Placebo TMS will be applied over the left inferior parietal lobule for approximately 3 minutes.

Trial Locations (1)

02129

Martinos Center for Biomedical Imaging, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER